目前低分子量肝素是ACS患者的推荐治疗。
It should now probably be the reference treatment for patients with ACS.
目的观察低分子量肝素对原发性肾病综合征的治疗作用。
Objective To observe the therapeutic effectiveness of low molecular weight heparin (LMWH) in the treatment of primary nephrotic syndrome.
那屈肝素钙在ACS治疗上是否比其他低分子量肝素有优势？
Does Nadroparin Calcium have any advantage in ACS treatment over other LMWHs?
目的比较低分子量肝素和尿激酶对肾小球炎症反应的保护作用。
Objective To investigate the protective effects of low-molecular heparin and urokinase on glomerular inflammation.
结论：本文建立的低分子量肝素钙注射液细菌内毒素检查法可行。
CONCLUSION:It is feasible to detect bacterial endotoxins in LMWHC by TAL test.
《国际循环》：对ACS患者通常你会选择使用哪种低分子量肝素？
International Circulation: Which LMWH would you normally choose to use in ACS patients?
结论低分子量肝素钠乳膏可以明显改善皮瓣血液循环，促进皮瓣成活。
Conclusion The blood circulation and survival of flap may be improved by heparin sodium cream.
目的：探讨缬沙坦和低分子量肝素对高糖刺激大鼠系膜细胞增殖的影响。
Objective: To observe the effect of valsartan and low molecular weight heparin on the proliferation of glomeruli mesangial cells stimulated by high glucose.
在普通肝素中按一定比例加入低分子量肝素将更有利于制品血栓安全性的提高。
The existence of certain amount of low-molecular-weight heparin in ordinary heparin would increase the thrombogenic safety of the concentrate more greatly.
观察低分子量肝素在血液透析中的抗凝效果，比较与普通肝素在护理方面的不同处理。
To observe the anticoagulation effect of low molecular weight heparin on hemodialysis and to study its related nursing aspect.
《国际循环》：目前有多种低分子量肝素，您能介绍一下几种低分子量肝素之间的区别吗？
International Circulation: at present, there are many kinds of LMWHs, would you like to introduce the differences among these LMWHs?
目的研究不同时间窗低分子量肝素治疗急性脑梗死的疗效及其对患者脑血流量和脑电图的影响。
Objective To observe the influence of low molecular weight heparin on cerebral blood flow and brain function in patients with acute cerebral infarction in different therapy time window.
结果：缬沙坦和低分子量肝素均可不同程度地抑制高糖刺激系膜细胞增殖，二者合用时作用增强。
Results: Both valsartan and low molecular weight heparin could significantly inhibit the proliferation of mesangial cells and when combined the effect was intensified.
结果：缬沙坦和低分子量肝素均可不同程度地抑制高糖刺激系膜细胞增殖，二者合用时作用增强。
Results:Both valsartan and low molecular weight heparin could inhibit the proliferation of mesangial cells significantly, and when combined the effect was intensified.
对于急性缺血性卒中患者，推荐不用全量抗凝，静脉输注或皮下注射低分子量肝素或类肝素(1b级)。
For patients with acute ischemic stroke, we recommend against full-dose anticoagulation with IV, sc, or LMWHs or heparinoids (Grade 1b).
目的进一步探讨活化的部分凝血活酶时间（APTT）对低分子量肝素（LMWH）治疗的实验监测价值。
Objective The aim of this study were to evaluate the value of activated partial thromboplastin time(APTT) in monitoring low-molecular weight heparin(LMWH).
方法：采用MTT比色法，观察缬沙坦和低分子量肝素不同作用时间和不同作用浓度以及二者合用时对高糖刺激系膜细胞增殖的影响。
Methods:The mesangial cell line was treated by valsartan and low molecular weight heparin under different concentrations and times, and the proliferation activity was measured by MTT.
目的测定低分子肝素的分子量及其分布。
OBJECTIVE To determine the molecular weight and molecular weight distribution of low molecular weight heparin (LMWH).
目的测定低分子肝素的分子量及其分布。
OBJECTIVE To determine the molecular weight and molecular weight distribution of low molecular weight heparin (LMWH).
应用推荐